# Merit Medical Systems, Inc.

> Merit Medical Systems develops, manufactures, and sells medical devices for interventional, diagnostic, and therapeutic procedures. Its portfolio spans disposable procedural tools, breast localization, dialysis access, embolotherapy, and endoscopy, serving hospitals, physicians, and medical-device manufacturers worldwide.

- **Founded:** 1987
- **Headquarters:** South Jordan, United States
- **Founders:** Fred P. Lampropoulos (Co-founder; former President and CEO), Kent W. Stanger (Co-founder; founding CFO), Darla Gill (Co-founder), William Padilla (Co-founder)
- **Products:** Coronary control syringes, SCOUT Radar Localization, WRAPSODY Cell-Impermeable Endoprosthesis, EsophyX Z+, Lead-management portfolio
- **Notable:** First syringe marketed in 1988, one year after founding., Expanded from procedural disposables into oncology, endoscopy, and dialysis-access devices., WRAPSODY received U.S. FDA premarket approval on December 19, 2024.

## Products & services

- **Coronary control syringes** — Disposable syringes used to deliver contrast during diagnostic cardiac procedures; Merit’s first syringe launched in 1988.
- **SCOUT Radar Localization** — Reflector-based, wire-free guidance to locate marked lesions and lymph nodes during surgery; added through the 2018 Cianna acquisition.
- **WRAPSODY Cell-Impermeable Endoprosthesis** — Endoprosthesis for specified dialysis-access stenoses; received U.S. premarket approval in December 2024.
- **EsophyX Z+** — Device for transoral incisionless fundoplication to treat selected patients with gastroesophageal reflux disease; assets acquired in July 2024.
- **Lead-management portfolio** — Devices and accessories for removal or replacement of cardiac-device leads; acquired from Cook in November 2024.
- **Merit OEM** — Components, finished devices, coatings, and pressure sensors for other medical-device manufacturers.
- **Think Education** — Physician-led courses, webinars, and clinical education covering interventional techniques.

## Achievements

- First syringe marketed in 1988, one year after founding.
- Expanded from procedural disposables into oncology, endoscopy, and dialysis-access devices.
- WRAPSODY received U.S. FDA premarket approval on December 19, 2024.
- Reported approximately US$1.516 billion in 2025 net sales.

## Latest updates

- **2026-10** — Third-quarter 2026 results scheduled for October 29, after the market closes; results had not been released as of this profile’s October 23 research date.
- **2026-07** — Reported Q2 2026 revenue of US$418.8 million, up 10% year over year, and GAAP operating margin of 14.4%.
- **2026-02** — Reported FY2025 net sales of approximately US$1.516 billion.
- **2025-10** — Martha G. Aronson became President and CEO on October 3, succeeding Fred Lampropoulos.

## Links

- Website: https://www.merit.com/
- LinkedIn: https://www.linkedin.com/company/merit-medical-systems-inc
- Twitter/X: https://twitter.com/meritmedical
- YouTube: https://www.youtube.com/user/meritmedical
- Instagram: https://www.instagram.com/meritmedical
- Facebook: https://www.facebook.com/meritmedicalsystems

---

Profile page: https://yespress.io/merit-medical-systems-inc
Published by YesPress — https://yespress.io
Last updated: 2026-10-23